AlphAIalphai — Financial news for AI agents
SEC EDGARJUN 21 min read$AXON

Kalinowski Caitlin Elizabeth sold $19K of AXON

Kalinowski Caitlin Elizabeth sold 40 shares of AXON ENTERPRISE, INC. (AXON) at $473.32 on 2026-06-01.

Original reporting
SEC EDGAR · Kalinowski Caitlin Elizabeth
Published Jun 2, 2026, 9:23 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 9:24 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$AXON
Neutral
low confidence
Mentioned
$AXON
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AXONNeutralLow
01

Why it matters

The disclosure updates insider activity records; it may slightly influence short-term sentiment but does not constitute new company fundamentals.

02

Market read

Traders may monitor for follow-on insider activity, but this specific transaction alone is unlikely to drive a material repricing.

03

What to watch

Form 4 size is small and timing may reflect personal cash needs; without follow-on insider buys or larger institutional changes, signal-to-noise is limited.

Relevance 6/10Novelty 7/10Timing: after-hours SEC Form 4 filed 2026-06-02 (sale dated 2026-06-01)

Background

The filing is an SEC Form 4 insider transaction for Axon Enterprise director Caitlin Elizabeth Kalinowski.

Company-level read

Ticker impact

$AXONNeutralLow confidence
Context

Director sold 40 shares of Axon Enterprise on 2026-06-01 for ~$18.9K via open-market sale, disclosed on SEC Form 4.

Expected impact

Low likelihood of a sustained price move; at most, minor intraday sentiment noise.

Evidence & confidence

This is an SEC Form 4 insider transaction with no accompanying fundamental catalyst; the article provides only the sale details and no indication of broader business changes.

Market effects

Sector

Minimal; single insider sale without sector-wide signal.

Regional

None.

Global

None.

Counterpoint

What could challenge this read

The sale may be routine liquidity/portfolio management and not a bearish signal, especially with no 10b5-1 plan details provided beyond 'No'.

Key entities

  • issuer
    AXON ENTERPRISE, INC.

    Company whose director reported an open-market sale of shares on 2026-06-01.

  • insider
    Kalinowski Caitlin Elizabeth

    Director who sold 40 shares at $473.32/share; holdings after sale: 4,156 shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

AXON insider trading history →

Related articles

AUG 23
$AXONMedAI 8/10

Axon’s AI Era Revenue Jumped Nearly 700%. Here’s What’s Behind It

Axon Enterprise (AXON) reported 35% revenue growth to $904M, beating estimates. AI Era revenue surged nearly 700% YoY. Management raised full-year guidance to 32-34% growth. Gross margin slipped 40 basis points to 62.9%. Analysts estimate a target price of $714, implying 13.7% upside over 2.4 years. The stock trades at 70x forward earnings, with growth driven by software and AI products.

tikr.com3 min
AUG 20
$BABAHighAI 8/10

Breakfast News: Alibaba's AI Push Comes at a Cost

Alibaba's Q1 revenue rose 9% to $39.6B, but operating income fell 57% due to tech investments. BILL Holdings reported 14% revenue growth and 80% operating income increase. U.S. debt surpassed $40T, with Treasury buybacks easing yield pressure. Apple plans 2027 launch for camera AirPods. Axon Enterprise passes competitive position tests, with a 69% potential upside to $1,088.08.

fool.com4 min
AUG 10
$AXONMed

Axon Stock Rebounds As Its Margin Squeeze Looks Like The Price Of Growth

Axon Enterprise (AXON) shares rose 9.3% on Friday after a 14.3% drop the prior session following its Q2 2026 results. The quarter showed revenue of $904 million, up 35% year over year, and a raised full-year outlook. The market disagreed over margin compression tied to higher memory costs and counter-drone hardware mix, with Axon expecting Q3 adjusted EBITDA margin to hold and rebuild in Q4.

finance.yahoo.com4 min
AUG 7
$AXONMed

Raise. So Why Is the Stock Down?

Axon Enterprise (NASDAQ: AXON) reported Q2 revenue of $904M, up 35% year over year, beating estimates of $876.5M. Adjusted EBITDA rose 40% to $242M, and adjusted EPS was $1.88 vs $1.84 expected. Axon raised full-year revenue guidance to 32%-34% growth but reduced software and services gross margin and withdrew operating cash flow and free cash flow guidance.

aol.com4 min